We are live on
!
Find out more
IC
IEQ Capital Portfolio holdings
AUM
$21.5B
1-Year Est. Return
75.26%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
+$644M
(+15%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
981
New
89
Increased
388
Reduced
336
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$47.1M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$47M |
| 3 |
Roblox
RBLX
|
+$27.7M |
| 4 |
Joby Aviation
JOBY
|
+$15.4M |
| 5 |
Apple
AAPL
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$12.8M |
| 2 |
CrowdStrike
CRWD
|
+$9.9M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$7.59M |
| 4 |
Silicon Laboratories
SLAB
|
+$7.54M |
| 5 |
Penumbra
PEN
|
+$7.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Communication Services | 13.07% |
| 3 | Consumer Discretionary | 6.86% |
| 4 | Healthcare | 6.72% |
| 5 | Financials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Consolidated Edison
ED
$40B
| $862K | 0.02% |
9,540
+1,532
| +19% | +$146K |
|
|
MRO
427
DELISTED
Marathon Oil Corporation
MRO
| $861K | 0.02% |
37,403
+3,557
| +11% | +$83.8K |
|
428
Jabil
JBL
$35.6B
| $860K | 0.02% |
7,965
-415
| -5% | -$36.5K |
|
429
Aptiv
APTV
$10.1B
| $855K | 0.02% |
8,377
-3,121
| -27% | -$309K |
|
430
Cardinal Health
CAH
$54.7B
| $852K | 0.02% |
9,014
+716
| +9% | +$60.5K |
|
431
Agilent Technologies
A
$39.3B
| $852K | 0.02% |
7,085
-2,925
| -29% | -$373K |
|
432
Vulcan Materials
VMC
$36.9B
| $851K | 0.02% |
3,773
-890
| -19% | -$171K |
|
433
WEC Energy
WEC
$35.6B
| $843K | 0.02% |
9,556
+2,844
| +42% | +$263K |
|
434
Expeditors International
EXPD
$23.7B
| $839K | 0.02% |
6,928
+865
| +14% | +$98.4K |
|
435
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $838K | 0.02% |
11,297
+2,797
| +33% | +$210K |
|
436
Roku
ROKU
$21.9B
| $837K | 0.02% |
13,093
+171
| +1% | +$10.4K |
|
437
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
| $828K | 0.02% |
9,946
+3,046
| +44% | +$232K |
|
438
McCormick & Company Non-Voting
MKC
$14B
| $827K | 0.02% |
9,479
+627
| +7% | +$55.4K |
|
439
Energy Transfer Partners
ET
$70B
| $822K | 0.02% |
64,712
+2,266
| +4% | +$28.7K |
|
440
Halliburton
HAL
$27B
| $818K | 0.02% |
24,790
+6
| +0% | +$190 |
|
441
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| $817K | 0.02% |
16,274
+10,602
| +187% | +$533K |
|
442
Moderna
MRNA
$22.8B
| $817K | 0.02% |
6,726
-1,969
| -23% | -$263K |
|
443
Otis Worldwide
OTIS
$28B
| $801K | 0.02% |
8,999
-2,647
| -23% | -$223K |
|
444
iShares Core US Aggregate Bond ETF
AGG
$138B
| $801K | 0.02% |
8,176
+488
| +6% | +$48.2K |
|
445
DTE Energy
DTE
$29.5B
| $794K | 0.02% |
7,222
+1,195
| +20% | +$133K |
|
446
Schwab Fundamental International Large Company Index ETF
FNDF
$25.2B
| $791K | 0.02% |
24,484
+357
| +1% | +$11.4K |
|
447
QuantumScape Corp
QS
$3.5B
| $785K | 0.02% |
98,249
-4,887
| -5% | -$34K |
|
|
ANSS
448
DELISTED
Ansys
ANSS
| $783K | 0.02% |
2,372
-258
| -10% | -$81.7K |
|
449
Western Midstream Partners
WES
$19.3B
| $782K | 0.02% |
29,474
-2,990
| -9% | -$78.7K |
|
450
Kraft Heinz
KHC
$31.6B
| $781K | 0.02% |
22,007
-4,928
| -18% | -$190K |
|
Similar funds
DSA
MMH
AM
VARA
SC
BA
IEQ Capital's Q2 2023 Portfolio in Review
As of Q2 2023, IEQ Capital held 981 positions worth $4.96B, up 15% from $4.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
IEQ Capital deployed $171M of net new capital in Q2 2023, opening 89 new positions and adding to 388 existing holdings. Its largest new stake was Neurocrine Biosciences: 481,268 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Salesforce, an estimated $12.8M trimmed.
- IEQ Capital's largest Q2 2023 buy was Neurocrine Biosciences: 481,268 shares worth $45.4M.
- IEQ Capital added most to Upbound Group in Q2 2023, an estimated $47.1M increase.
- IEQ Capital's biggest Q2 2023 reduction was Salesforce, cutting an estimated $12.8M.
- IEQ Capital fully exited Penumbra in Q2 2023, selling an estimated $7.08M.
- IEQ Capital's ten largest holdings make up 38% of its $4.96B portfolio in Q2 2023.
- IEQ Capital opened 89 new positions and closed 81 in Q2 2023.
- IEQ Capital's portfolio value rose 15% quarter-over-quarter to $4.96B.
Based on IEQ Capital's 13F filing for Q2 2023, filed 8 Aug 2023.